ipilumab monoclonal antibody drug. targets ctla-4 (immune checkpoint inhibitor) and is used in the treatment of cancer. generic

antibody antigen biological biosimilar biotech biotechnology blockade cancer checkpoint combination ctla4 cytotoxic disease drug immune immunoglobulin immunology immunooncology immunotherapy infusion inhibitor injection inn ipilumab lymphocyte lymphocyteassociated mab melanoma monoclonal neoantigen nomenclature oncology peptide protein tumor